How to elevate concerns of bias or inappropriate behavior
Jun 23 @ 7:00 am – 8:00 am

How to elevate concerns of bias or inappropriate behavior: Ombudsperson, Deans GME & Graduate/Postdocs, Academic Affairs, Human Resources

UP(by) stander training
Jun 30 @ 7:00 am – 8:00 am

UP(by) stander training: Dr. Magali Fassiotto, Assistant Dean for Faculty Development and Diversity Stanford University School of Medicine

Strategies to combat bias and increase diversity
Jul 7 @ 7:00 am – 8:00 am

Strategies to combat bias and increase diversity: Dr. Hannah Valentine Chief Officer for Scientific Workforce Diversity at the United States National Institutes of Health.

Diversity Lecture: Fatima Stanford, MD, MPH, MPA
Mar 2 @ 7:00 am – 8:00 am

Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FAHA, FTOS is an obesity medicine physician scientist, educator, and policy maker at Massachusetts General Hospital and Harvard Medical School.

Culturally-Inclusive Food Fair II
Apr 26 @ 12:00 pm – 2:00 pm
Culturally-Inclusive Food Fair II @ Huang Building Lawn

When: Tuesday, April 26, 2022, from 12pm to 2pm

Where: 780 Welch Road Lawn

What: Celebrating diversity through food! This event will honor Asian American and Pacific Islander Heritage Month (MAY)

24th Annual Fogarty Lecture
Sep 30 @ 4:00 pm – 5:00 pm

Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer.  The date of the event is Friday September 30, 2022 at 4pm.  It will be a hybrid event.

Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.

Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.

Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.

Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.

Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.